In 1974,Andreas Grüntzig developed the technique“percutaneous transluminal dilatation”using the first balloon angioplasty,and for this he was awarded the Nobel Prize in Physiology or Medicine.Balloon angioplasty he...
supported by the Zhejiang Provincial Natural Science Foundation of China(LTGY24H180019);Basic Medical and Health Science Technology Projects of Wenzhou City(Y20220132);Medical and Health Science and Technology Project of Zhejiang Province(2023RC210 and 2024KY160).
Acute morphological changes in de novo coronary lesions after drug-coated balloon(DCB)angioplasty can affect endothelial mechanics and consequently clinical outcomes.Angiography-based computational modeling has been v...
The incidence of acute myocardial infarction (AMI) is increasing year by year, which seriously endangers human health around the world. The preferred treatment strategy for AMI patients is the use of drug-eluting sten...
supported by the Medical Science and Technique Research Plan of He’nan Province(Provincial and Ministerial Co-construction Project)(SB201901027).
BACKGROUND Controversy exists as to the optimal treatment approach for ostial left anterior descending(LAD)or ostial left circumflex artery(LCx)lesions.Drug-coated balloons(DCB)may overcome some of the limitations of ...
Supported by Shandong Provincial TCM Science and Technology Development Program Project,No.2019-0481;Jining City Science and Technology Key Research and Development Program,No.2021YXNS069.
BACKGROUND Percutaneous transluminal coronary angioplasty,while an effective intervention,can frequently lead to acute occlusion with severe consequences.Although clinical trials have demonstrated the efficacy of drug...
the Natural Science Foundation of China(no.81700321).
Background:Drug-coated balloons(DCBs)are an up-and-coming tactic in treating in-stent restenosis and coronary artery small vessel disease,but their efficacy in treating acute myocardial infarction needs to be further ...
Peripheral Artery Disease (PAD) is a global disease that affects more than 200 million individuals worldwide with an ever-increasing prevalence rate from year to year. Peripheral Artery Disease treatments include ever...
Objective:To evaluate the efficacy of paclitaxel-coated balloon(PCB)in the treatment of extra-long femoropopliteal artery atherosclerotic disease(>30 cm).Materials and methods:Forty-nine patients with extra-long femor...
Objective To evaluate the efficacy and safety of drug-coated balloons(DCB)for de novo large coronary vessels.Methods One hundred and two patients were retrospectively enrolled in this study,there were 104 lesions with...
Drug-eluting balloons (DEBs) represent an enhancement of the therapeutic repertoire for the interventional cardiologist. The therapeutic concept of DEBs is promising, notably on the basis of initial studies in patient...